Mumbai, Supriya Lifescience, which is into expansion mode, is eyeing up to Rs 1,600 crore revenue from its Lote MIDC in Ratnagiri and Ambernath facilities in the next three years, a top company ...
RATNAGIRI: Mumbai-based bulk drug manufacturer Supriya Lifescience is targeting more than a two-fold increase in annual revenue to Rs 1,600 crore over the next three years, from about Rs 700 crore in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results